Methadone/Buprenorphine Cross-Over Study

Purpose:

The purpose of this study is to explore ways to cross patients over from methadone to buprenorphine.

Criteria:

Inclusion Criteria: M/F ages 21-50. Opiate dependence according to DSM-IV critera. Self-reported use within the last 30 days. Agreeable to conditions of study and signed informed consent. Exclusion Criteria: Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative-hynotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.

NCT ID:

NCT00000208

Primary Contact:

Principal Investigator
Walter Ling, M.D.
Friends Research Institute, Inc.

Backup Contact:

N/A

Location Contact:

Los Angeles, California 90025
United States



There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.